A detailed history of Clarius Group, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Clarius Group, LLC holds 20,801 shares of JNJ stock, worth $3.46 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
20,801
Previous 21,566 3.55%
Holding current value
$3.46 Million
Previous $3.41 Million 10.88%
% of portfolio
0.22%
Previous 0.24%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$144.38 - $157.78 $110,450 - $120,701
-765 Reduced 3.55%
20,801 $3.04 Million
Q1 2024

Apr 17, 2024

SELL
$155.22 - $162.74 $847,345 - $888,397
-5,459 Reduced 20.2%
21,566 $3.41 Million
Q4 2023

Jan 29, 2024

BUY
$145.6 - $158.88 $417,872 - $455,985
2,870 Added 11.88%
27,025 $4.24 Million
Q3 2023

Oct 19, 2023

SELL
$155.75 - $174.48 $1.13 Million - $1.26 Million
-7,240 Reduced 23.06%
24,155 $3.76 Million
Q2 2023

Aug 09, 2023

BUY
$154.35 - $166.11 $355,468 - $382,551
2,303 Added 7.92%
31,395 $5.2 Million
Q1 2023

Apr 17, 2023

SELL
$151.05 - $180.26 $514,627 - $614,145
-3,407 Reduced 10.48%
29,092 $4.51 Million
Q4 2022

Jan 25, 2023

SELL
$160.2 - $179.79 $14,417 - $16,181
-90 Reduced 0.28%
32,499 $5.74 Million
Q3 2022

Oct 24, 2022

BUY
$161.33 - $179.52 $323,627 - $360,117
2,006 Added 6.56%
32,589 $5.32 Million
Q2 2022

Aug 10, 2022

BUY
$168.19 - $186.01 $272,467 - $301,336
1,620 Added 5.59%
30,583 $5.43 Million
Q4 2021

Feb 02, 2022

BUY
$155.93 - $173.01 $60,344 - $66,954
387 Added 1.35%
28,963 $4.96 Million
Q3 2021

Oct 18, 2021

BUY
$161.5 - $179.47 $97,869 - $108,758
606 Added 2.17%
28,576 $4.62 Million
Q2 2021

Aug 06, 2021

BUY
$159.48 - $171.07 $148,954 - $159,779
934 Added 3.45%
27,970 $4.61 Million
Q1 2021

Apr 27, 2021

BUY
$153.07 - $170.48 $439,463 - $489,448
2,871 Added 11.88%
27,036 $4.44 Million
Q4 2020

Jan 15, 2021

BUY
$137.11 - $157.38 $256,944 - $294,930
1,874 Added 8.41%
24,165 $3.8 Million
Q3 2020

Oct 09, 2020

SELL
$140.38 - $153.83 $615,847 - $674,852
-4,387 Reduced 16.44%
22,291 $3.32 Million
Q2 2020

Jul 08, 2020

BUY
$128.81 - $155.51 $934,902 - $1.13 Million
7,258 Added 37.37%
26,678 $3.75 Million
Q1 2020

Apr 24, 2020

BUY
$111.14 - $153.99 $197,940 - $274,256
1,781 Added 10.1%
19,420 $2.55 Million
Q4 2019

Jan 22, 2020

SELL
$127.5 - $146.44 $4,335 - $4,978
-34 Reduced 0.19%
17,639 $2.59 Million
Q3 2019

Oct 23, 2019

SELL
$126.95 - $142.14 $84,548 - $94,665
-666 Reduced 3.63%
17,673 $2.29 Million
Q2 2019

Aug 02, 2019

BUY
$131.15 - $144.24 $703,750 - $773,991
5,366 Added 41.36%
18,339 $2.55 Million
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $800,836 - $890,462
6,370 Added 96.47%
12,973 $1.81 Million
Q4 2018

Feb 11, 2019

BUY
$122.84 - $147.84 $228,850 - $275,425
1,863 Added 39.3%
6,603 $852,000
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $576,289 - $677,251
4,740 New
4,740 $655,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.